SEARCH

SEARCH BY CITATION

References

  • 1
    Lenzer J. US cancer mortality falls for the first time [serial online]. BMJ. 2006; 332: 444.
  • 2
    Blackman DJ, Masi CM. Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol. 2006; 24: 2170-2178.
  • 3
    Irby K, Anderson WF, Henson DE, Devesa SS. Emerging and widening colorectal carcinoma disparities between blacks and whites in the United States (1975-2002). Cancer Epidemiol Biomarkers Prev. 2006; 15: 792-797.
  • 4
    Polite BN, Dignam JJ, Olopade OI. Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol. 2006; 24: 2179-2187.
  • 5
    Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006; 56: 168-183.
  • 6
    Chu KC, Lamar CA, Freeman HP. Racial disparities in breast carcinoma survival rates: separating factors that affect diagnosis from factors that affect treatment. Cancer. 2003; 97: 2853-2860.
  • 7
    Bigby J, Holmes MD. Disparities across the breast cancer continuum. Cancer Causes Control. 2005; 16: 35-44.
  • 8
    Bickell NA, LePar F, Wang JJ, Leventhal H. Lost opportunities: physicians' reasons and disparities in breast cancer treatment. J Clin Oncol. 2007; 25: 2516-2521.
  • 9
    Bickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006; 24: 1357-1362.
  • 10
    Du Xianglin L, Gor BJ. Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis. 2007; 17: 122-128.
  • 11
    Joslyn SA. Racial differences in treatment and survival from early-stage breast carcinoma. Cancer. 2002; 95: 1759-1766.
  • 12
    Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003; 163: 49-56.
  • 13
    Naeim A, Hurria A, Leake B, Maly RC. Do age and ethnicity predict breast cancer treatment received? A cross-sectional urban population based study. Breast cancer treatment: age and ethnicity. Crit Rev Oncol Hematol. 2006; 59: 234-242.
  • 14
    Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334-357.
  • 15
    Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol. 2005; 23: 6639-6646.
  • 16
    Tammemagi CM. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opinion Obstet Gynecol. 2007; 19: 31-36.
  • 17
    Byers TE, Wolf HJ, Bauer MS, et al. The impact of socioeconomic status on survival after cancer in the United States. Cancer. 2008; 5: 241-246.
  • 18
    Kim SH, Ferrante J, Won BR, Hammeed M. Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for black women after breast cancer treatment. J Surg Oncol. 2008; 6: 26-29.
  • 19
    Thomas BC, Thomas I, Nandamohan V, Nair MK, Pandey M. Screening for distress can predict loss of follow-up and treatment in cancer patients: results of development and validation of the Distress Inventory for Cancer Version 2 [serial online]. Psychooncology. 2009; 18: 524-533.
  • 20
    Kirk MC, Hudis CA. Insight into barriers against optimal adherence to oral hormonal therapy in women with breast cancer. Clin Breast Cancer. 2008; 8: 155-161.
  • 21
    Magai C, Consedine N, Neugut AI, Hershman DL. Common psychosocial factors underlying breast cancer screening and breast cancer treatment adherence: a conceptual review and synthesis. J Womens Health (Larchmt). 2007; 16: 11-23.
  • 22
    Vargas RB, Ryan GW, Jackson CA, Rodriquez R, Freeman HP. Characteristics of the original patient navigation programs to reduce disparities in the diagnosis and treatment of breast cancer. Cancer. 2008; 113: 426-433.
  • 23
    Gabram SG, Lund MJ, Gardner BS, et al. Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer. 2008; 113: 602-607.
  • 24
    Ell K, Vourlekis B, Lee P-J, Xie B. Patient navigation and case management following an abnormal mammogram: a randomized clinical trial. Prev Med. 2007; 44: 26-33.
  • 25
    Meyerowitz BE, Richardson J, Hudson S, Leedham B. Ethnicity and cancer outcomes: behavioral and psychosocial considerations. Psychol Bull. 1998; 123: 47-70.
  • 26
    Bruner DW, Jones M, Buchanan D, Russo J. Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. J Clin Oncol. 2006; 24: 2209-2215.
  • 27
    Gross CP, Smith BD, Wolf E, Andersen M. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer. 2008; 112: 900-908.
  • 28
    Curtis E, Quale C, Haggstrom D, Smith-Bindman R. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, co-morbidities and demographics? Cancer. 2008; 112: 171-180.
  • 29
    Schleinitz MD, DePalo D, Blume J, Stein M. Can differences in breast cancer utilities explain disparities in breast cancer care? J Gen Intern Med. 2006; 21: 1253-1260.
  • 30
    Formenti SC, Meyerowitz BE, Ell K, et al. Inadequate adherence to radiotherapy in Latina immigrants with carcinoma of the cervix: potential impact on disease free survival. Cancer. 1995; 75: 1135-1140.
  • 31
    Levine AM, Richardson JL, Marks G, et al. Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol. 1987; 5: 1469-1476.
  • 32
    Richardson JL, Marks G, Johnson CA, et al. Path model of multidimensional compliance with cancer therapy. Health Psych. 1987; 6: 183-207.
  • 33
    Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol. 1990; 8: 356-364.
  • 34
    Li BD, Brown WA, Ampil F, Burton G, Yu H, McDonald JC. Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conversation therapy. Ann Surg. 2000; 231: 883-889.
  • 35
    Srokowski TP, Fang S, Duan Z, et al. Completion of adjuvant radiation therapy among women with breast cancer. Cancer. 2008; 113: 22-39.
  • 36
    Dobie SA, Baldwin LM, Dominitz JA, et al. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst. 2006; 98: 610-619.
  • 37
    Becker M, Drachman R, Kirscht P. A new approach to explaining sick-role behavior in low-income populations. Am J Pub Health. 1974; 64: 205-216.
  • 38
    Bernal G, Bonilla J, Bellido C. Ecological validity and cultural sensitivity for outcome research: issues for the cultural adaptation and development of psychosocial treatments with Hispanics. J Abnormal Psychol. 1995; 23: 67-82.
  • 39
    Ruiz P. The role of culture in psychiatric care. Am J Psychiatry. 1998; 155: 1763-1765.
  • 40
    Cleeland CS. Pain assessment in cancer. In: OsabaD, ed. Effect of Cancer on Quality of Life. Boca Raton, Fla: CRC Press; 1991: 293-305.
  • 41
    Anderson K, Mendoza T, Valero V, et al. Minority cancer patients and their providers: pain management attitudes and practice. Cancer. 2000; 88: 1929-1938.
  • 42
    Mor V, Laliberte L, Morris JN, Wiermann M. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. J Clin Oncol. 1984; 2: 1170-1176.
  • 43
    Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E. The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol. 1993; 11: 570-579.
  • 44
    Cella D, Hernandez L, Corona M, et al. Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument. Med Care. 1998; 36: 1407-1417.
  • 45
    Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606-613.
  • 46
    Wittkampf KA, Naeije L, Schene AH, et al. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen Hosp Psych. 2007; 29: 388-395.
  • 47
    Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983; 13: 595-605.
  • 48
    Willms DG, Best JA, Taylor DW, et al. A systematic approach for using qualitative methods in primary prevention research. Med Anthropol Q. 1990; 4: 391-409.
  • 49
    Glaser BG, Strauss AL. The Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago, Ill: Aldine; 1967.
  • 50
    Strauss AL, Corbin J. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. Thousand Oaks, Calif: Sage Publications; 1998.
  • 51
    Miles MB, Huberman AM. Qualitative Data Analysis: An Expanded Sourcebook. 2nd ed. Thousand Oaks, Calif: Sage Publications; 1994.
  • 52
    Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcome. CA Cancer J Clin. 2008; 58: 9-31.
  • 53
    Ell K, Xie B, Wells A, et al. Economic stress among low-income women with cancer: effects on quality of life. Cancer. 2008; 112: 616-625.
  • 54
    Dwight-Johnson M, Ell K, Lee PJ. Can collaborative care address the needs of low-income Latinas with comorbid depression and cancer? Results from a randomized pilot study. Psychosomatics. 2005; 46: 224-232.
  • 55
    Ell K, Xie B, Quon B, et al. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol. 2008; 26: 4488-4496.
  • 56
    Strong V, Waters R, Hibberd C, et al. Management of depression for people with cancer (SMaRT Oncology 1): a randomised trial. Lancet. 2008; 372: 40-48.
  • 57
    Moore S. Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs. 2007; 30: 112-122.
  • 58
    Wells KJ, Battaglia TA, Dudley DJ, et al. Patient navigation: state of the art or is it science? Cancer. 2008; 113: 1999-2010.
  • 59
    Freund KM, Battaglia TA, Calhoun E, et al. National Cancer Institute Patient Navigation Research Program. Cancer. 2008; 113: 3391-3399.